C6H10N2, triclinic, P1‾$‾{1}$ (no. 2), a = 7.4423(5) Å, b = 7.9420(5) Å, c = 11.6711(8) Å, α = 96.667(3)°, β = 95.650(3)°, γ = 100.999(3)°, V = 667.42(8) Å3, Z = 4, Rgt(F) = 0.0620, wRref(F2) = 0.1681, T = 200 K
The crystal structure of N-methyl -2(p-octyl phenoxy) benzimidazole has been determined by X-ray met...
C26H36N6, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.7137(2) Å, b = 10.4374(3) Å, c = 11.1141(3) Å,...
C26H30N10I4Cd2, monoclinic, P21/n (no. 14), a = 8.1164(10) Å, b = 15.9401(18) Å, c = 13.5531(17) Å, ...
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.88...
C36H60Cl2CuN12, monoclinic, P21/c (no. 14), a = 8.3112(2) Å, b = 15.9513(4) Å, c = 17.1068(4) Å, β =...
C5H8N2, monoclinic, P21/n (no. 14), a = 8.2492(6) Å, b = 7.2496(5) Å, c = 9.2882(7) Å, β = 99.214(2)...
C4H6O2N4, monoclinic, P2/c (no. 13), a = 14.6016(14) Å, b = 6.2077(6) Å, c = 12.9876(11) Å, β = 100....
R factor = 0.040; wR factor = 0.104; data-to-parameter ratio = 18.0. In the title compound, C13H10N2...
C17H22N2O3, monoclinic, P21/c, (no. 14) a = 18.419(4) Å, b = 5.7524(12) Å, c = 17.575(4) Å, β = 117....
R factor = 0.035; wR factor = 0.088; data-to-parameter ratio = 18.3. In the title compound, C19H22N2...
C22H15N3O2, triclinic, P1‾$P‾{1}$ (no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) ...
The crystal and molecular structures of 1-Methyl-2-Isopropyl-5-Nitroimidazole (A) and 1-Methyl-2(Thi...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...
The crystal structures of three benzimidazole esters containing aryl or heterocyclic substituents at...
The crystal structures of three benzimidazole esters containing aryl or heterocyclic substituents at...
The crystal structure of N-methyl -2(p-octyl phenoxy) benzimidazole has been determined by X-ray met...
C26H36N6, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.7137(2) Å, b = 10.4374(3) Å, c = 11.1141(3) Å,...
C26H30N10I4Cd2, monoclinic, P21/n (no. 14), a = 8.1164(10) Å, b = 15.9401(18) Å, c = 13.5531(17) Å, ...
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.88...
C36H60Cl2CuN12, monoclinic, P21/c (no. 14), a = 8.3112(2) Å, b = 15.9513(4) Å, c = 17.1068(4) Å, β =...
C5H8N2, monoclinic, P21/n (no. 14), a = 8.2492(6) Å, b = 7.2496(5) Å, c = 9.2882(7) Å, β = 99.214(2)...
C4H6O2N4, monoclinic, P2/c (no. 13), a = 14.6016(14) Å, b = 6.2077(6) Å, c = 12.9876(11) Å, β = 100....
R factor = 0.040; wR factor = 0.104; data-to-parameter ratio = 18.0. In the title compound, C13H10N2...
C17H22N2O3, monoclinic, P21/c, (no. 14) a = 18.419(4) Å, b = 5.7524(12) Å, c = 17.575(4) Å, β = 117....
R factor = 0.035; wR factor = 0.088; data-to-parameter ratio = 18.3. In the title compound, C19H22N2...
C22H15N3O2, triclinic, P1‾$P‾{1}$ (no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) ...
The crystal and molecular structures of 1-Methyl-2-Isopropyl-5-Nitroimidazole (A) and 1-Methyl-2(Thi...
C16H11Cl2FN2, orthorhombic, Pbca (no. 61), a = 9.6732(3) Å, b = 15.5602(5) Å, c = 19.0881(6) Å, V = ...
The crystal structures of three benzimidazole esters containing aryl or heterocyclic substituents at...
The crystal structures of three benzimidazole esters containing aryl or heterocyclic substituents at...
The crystal structure of N-methyl -2(p-octyl phenoxy) benzimidazole has been determined by X-ray met...
C26H36N6, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.7137(2) Å, b = 10.4374(3) Å, c = 11.1141(3) Å,...
C26H30N10I4Cd2, monoclinic, P21/n (no. 14), a = 8.1164(10) Å, b = 15.9401(18) Å, c = 13.5531(17) Å, ...
DOI
Add to ORKG